NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/12/2024
Voltar para busca
Dado oficial do USPTO
NEREUS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
NEREUS
ST13
US500000097650292Classe
1, 5, 9, 10, 24
Pedido
97650292
Registro
7583486
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
03/12/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 10, 24
Data de depósito
27/10/2022
Data de registro
03/12/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/12/2024
Última transação
03/12/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Comberton, Cambridge, GB
Examinador
KLUWE, CHERYL
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
ASTREA UK SERVICES LIMITED
Representantes
Ben Natter HAUG PARTNERS, LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10Classe 24
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Nanofiber filtering compositions for proteinnucleic acidviral particle extracellular vesicle and advanced therapeutic medicinal product purification; nanofiber filtering materials for proteinnucleic acidviral particleextracellular vesicle and advanced therapeutic medicinal product purification; biochemical and chemical preparation material for chromatographic purification of chemical and biological substances other than for medical or veterinary purposes; biochemical and chemical preparation substrates for chromatographic purification of substances comprising of chemicals and biologicals other than for medical or veterinary purposes; chemical and biological absorbents and adsorbents for recovery of viral particles and nucleic acids for development of viral vectorsextracellular vesicles and advanced therapeutic medicinal products; chemical and biological purifying agents for chromatographic purification of chemical and biological preparations other than for medical or veterinary purposes; chemicals and biologicals for use in bioseparation for protein purificationnucleic acid purificationviral particle purification extracellular vesicle purification and purification of advanced therapeutic medicinal products; chemicals and biologicals for use in filtering of proteinsnucleic acidsviral particlesextracellular vesicles and advanced therapeutic medicinal products; chemical and biological substances for use in separation for protein purificationnucleic acid purificationviral particle purificationextracellular vesicle purification and purification of advanced therapeutic medicinal product; fibres of inorganic material for separation purposes for viral particle purification; fibres of organic material for separation purposes for proteinnucleic acidviral particleextracellular vesicle and advanced therapeutic medicinal product purification; raw proteins for scientific and medical research; proteins for scientific and industrial use; enzymes for scientific and industrial usereagents for scientific and research use other than for medical use; ligands for scientific and research use; biochemicalantibodies and antibody fragments for in vitro scientific or research use.
Classe 5
Proteins for medical diagnostic purposes; enzymes for medical use; nucleic acids for medical use; extracellular vesicles for medical use; advanced therapeutic medicinal products for medical use; proteinsnamely nucleic acids for medical use; proteinsnamely extracellular vesicles for medical use; proteinsnamely advanced therapeutic medicinal products for medical use; medical and clinical diagnostic reagents; insulin and insulin analogues biochemical and chemical preparation material for chromatographic purification of chemical and biological substancesfor medical or veterinary purposes; biochemical and chemical preparation substrates for chromatographic purification of substances comprising of chemicals and biologicalsfor medical or veterinary purposes; chemical and biological purifying agents for chromatographic purification of chemical and biological preparationsfor medical or veterinary purposes.
Classe 9
Scientific research and laboratory apparatuslaboratory filters for proteinnucleic acidviral particleextracellular vesicle and advanced therapeutic medicinal product purification; scientific purification apparatuslaboratory filters used for proteinnucleic acidviral particle extracellular vesicle and advanced therapeutic medicinal product purification; laboratory filters and purifiers for proteinnucleic acidviral particleextracellular vesicle and advanced therapeutic medicinal product purification; filtering and separation apparatus for proteinnucleic acidviral particle extracellular vesicle and advanced therapeutic medicinal product purification; apparatus for bioseparation for proteinnucleic acidviral particle extracellular vesicle and advanced therapeutic medicinal product purification; membranes and nanofibers for filtration for laboratory use; separation columns and separation devices for scientific purposes; bioprocessing columns for scientific purposes; chromatography apparatus and instruments for scientific purposes; temperaturepressure and optical sensors for bioprocessing apparatus and equipment.
Classe 10
Diagnosticexamination and monitoring equipmentmedical diagnostic apparatus for filtering and testing of proteinsnucleic acidsviral particles and extracellular vesicles; purification apparatus for filtering and testing of proteinsnucleic acidsviral particles extracellular vesicle and advanced therapeutic medicinal product for medical purposes; filtering and separation apparatus for filtering and testing of proteinsnucleic acidsviral particlesextracellular vesicles and advanced therapeutic medicinal products for medical purposes; medical and veterinary apparatus for bioseparationproteinnucleic acidviral particle and extracellular vesicle separation apparatus; membranes and nanofibres for filtration being filters for medical purposesproteinnucleic acidviral particle and extracellular vesicle filters; separation instruments for medical use being filters for medical purposesproteinnucleic acidviral particle and extracellular vesicle filters.
Classe 24
Composite electrospun nanofiber material for use in proteinnucleic acidviral particleextracellular vesicle and advanced therapeutic medicinal product filtration; composite electrospun nanofibre textiles for use in proteinnucleic acidviral particleextracellular vesicle and advanced therapeutic medicinal product filtration; composite electrospun nanofiber filtering cloth for use in proteinnucleic acidviral particleextracellular vesicle and advanced therapeutic medicinal product filtration and purification.
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
03/12/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/10/2024
PUBO
PUBLISHED FOR OPPOSITION
01/10/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/09/2024
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
22/08/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/08/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
16/04/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
16/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/04/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
16/04/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
30/01/2024
GNFR
FINAL REFUSAL E-MAILED
30/01/2024
CNFR
FINAL REFUSAL WRITTEN
30/01/2024
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
16/10/2023
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
16/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/10/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/10/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
17/07/2023
GNRT
NON-FINAL ACTION E-MAILED
17/07/2023
CNRT
NON-FINAL ACTION WRITTEN
17/07/2023
DOCK
ASSIGNED TO EXAMINER
24/06/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/11/2022
NWAP
NEW APPLICATION ENTERED
31/10/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NEREUS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.